Vertex Pharmaceuticals to invest £300 million at Harwell Campus

Vertex Pharmaceuticals to invest £300 million at Harwell Campus.
In:

Good morning,

We have 10 deals this week, taking in Vertex Pharmaceuticals' investment of over £300 million in a research facility at Harwell Campus and Illumina's lease extension at Potsdamer Platz in Berlin. Let's dive into it.

In today's free edition:

🇬🇧 Vertex to invest over £300 million in Harwell, Oxfordshire
🇩🇪 Illumina extends lease on Berlin Solutions Center

🔒 For paying members only:
🇮🇪 €6 million medical-anchored centre for sale in Dublin
🇸🇪 Lab and office building opens in Västra Götaland
🇬🇧 Occupier takes 1,600 sq ft of London lab space
🇩🇪 Medical supplier consolidates warehousing in Bremen region
🇬🇧 Clinical trials firm moves to new Scottish hub
🇨🇭 Swiss group expands bioconjugation capacity in Valais
🇬🇧 £11 million East of England science park refurbishment
🇩🇰 University advances 7,000 sq m Danish cleanroom building

Subscribe here to unlock.

Enjoy today's newsletter,

Stephen Ryan


🇬🇧 Vertex Pharmaceuticals to invest over £300 million at Harwell Campus

Harwell Campus (source: harwellcampus.co.uk)

Vertex Pharmaceuticals will invest over £300 million in a 155,000 sq ft research facility at Harwell Campus, according to the government's Budget document.

Construction is due to begin in early 2027.

The project is one of three public-private investments announced in the Budget, which total over £1 billion and are backed by almost £70 million in grant funding.

The Budget also confirmed a pilot financing model for the Greater Cambridge Development Corporation, and a consultation on a development corporation for Oxford is due by year-end.


🇩🇪 Illumina extends 1,687 sq m lease at Potsdamer Platz in Berlin

Atrium Tower at Potsdamer Platz, Berlin (source: potsdamer-platz.net)

Genomics company Illumina has extended its lease on 1,687 sq m in the Atrium Tower at Potsdamer Platz by five years, securing the space until 2032.

CBRE advised Illumina, while developer and operator BGRE represented the owner.

The premises house Illumina's regional Solutions Center, which combines office, laboratory and training space at a single site. Customers use the centre for hands-on work with the company's sequencing, multiomics and analysis technologies.

The renewal follows recent lettings at Potsdamer Platz to Neko Health, Zentiva and Focused Energy.

Written by
Stephen Ryan
Stephen is an independent real estate researcher and CFA charterholder who founded Life Sciences Real Estate in 2022.

Stay on top of the life sciences real estate markets in Europe

Join us
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to Life Sciences Real Estate.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.